New platform launches from stealth to index the world’s ephemeral speech data, helping institutional decision-makers detect convergences and divergences before they reach market consensus

SAN FRANCISCO, July 23, 2026 — Cast Insights today announced the launch of its AI-powered platform that turns spoken content into competitive intelligence for high-stakes decision makers, alongside a $4.5 million pre-seed funding round. The round was led by Abstract Ventures, with participation from HF0, Village Global, Max Ventures, Embassy Ventures, Stratus Ventures, and others. The funding will accelerate Cast Insights’ mission to ingest and analyze publicly available spoken word at a global scale.

The company is built on a simple but disruptive premise: the future is often a comforting story we create because we don’t fully understand the present. Rather than relying on traditional forecasting, Cast Insights focuses on understanding reality as it happens, constantly gathering and interpreting large amounts of public conversation to identify convergences, the recurring patterns and signals emerging across society, markets, and institutions, and divergences, the breaks from those patterns that signal new disruptions. In this view, tomorrow is not a guess, but the continuation or interruption of forces already at work today.

Using AI, Cast Insights ingests spoken audio from thousands of sources worldwide and transforms it into a real-time intelligence layer. At the center of the platform is what the company calls ephemeral speech data, a new category of real-time intelligence built from spoken information that is everywhere, constantly renewing, and disappearing almost as soon as it is created. Beyond simply transcribing speech, Cast Insights analyzes who is speaking, what is being said, when it’s happening, and how narratives and sentiment evolve over time, creating a permanent, searchable record of data of what would otherwise vanish. Built for investors, policy teams, corporate strategists, and newsrooms, the platform ensures that insights spoken across the world no longer vanish in real time and instead, become discoverable and actionable as they unfold.

“We’ve always had this strange cultural obsession with forecasting the future, when the real problem is that we barely understand the present,” said Otávio Costa Miranda, CEO and Co-Founder of Cast Insights. “Most of what gets said in the world every day across radio stations, legislatures, podcasts, local broadcasts is ephemeral by nature. It surfaces publicly, it influences people, and then it vanishes. We call this ephemeral speech data, and it’s the largest uncaptured dataset in the world. What Cast does is make the present legible in real time so that instead of guessing where things are going, our clients can see convergences forming and divergences emerging before they reach consensus. The signal is always there. It just slips through everyone’s fingers.”

The volume of ephemeral speech data is staggering and largely untapped. Currently, there are more than 4.5 million podcasts and 185 million episodes existing globally, alongside more than 44,000 radio stations broadcasting across 100+ languages and geographies, each one a constant stream of public content.

Since its launch, Cast Insights has gathered more than 2.3 million hours of speech data from over 20 countries and 10 languages. In the coming weeks, the company plans to scale to 20 million hours processed and 500,000 hours of live content monitored daily, at which point it will have built the largest American ephemeral speech dataset in the world, covering every major radio station and television broadcast across the country, plus podcasts at scale.

Cast Insights was invited to join the HF0 Residency, the most exclusive startup programs for repeat founders. HF0 only takes 10 teams per cohort, with the goal of achieving 12 months of business growth in 12 weeks.

“When we first met Otto and the team, we had this moment that keeps happening with the best founders we back, we thought, ‘Wait, that doesn’t exist yet? How does that not exist?'” said Evan Stites-Clayton from HF0. “Once Otto showed us the platform’s features like real-time alerts within thirty seconds of broadcast, speaker-level voice tracking, narrative curves across thousands of sources, it became very clear this team is building something the entire institutional world is going to depend on. This is the kind of company where every week you peel back another layer and it just gets bigger.”

Cast Insights is available to institutional clients, with pricing available upon request. To learn more, please visit: https://castinsights.com/.

About Cast Insights

Founded in 2025, Cast Insights is a leading real-time spoken intelligence platform that ingests public speech from television, radio, podcasts, and livestreams and transforms it into structured, real-time insights. By converting speech into searchable data, Cast Insights enables hedge funds, policy teams, strategy groups, and newsrooms to track emerging narratives, compare statements across time and sources, and receive alerts the moment something meaningful is said. The platform replaces manual monitoring and fragmented listening with a living, queryable archive of the spoken world, allowing organizations to move faster, think more clearly, and act with greater confidence. Cast Insights is headquartered in San Francisco and is backed by leading investors, including Abstract Ventures, Village Global, HF0, Max Ventures, and Founder Embassy. To learn more, visit: https://castinsights.com/ 

SOURCE Cast Insights

More than a name change: the launch marks the company’s evolution from fractional engineering into a suite of specialized AI agents, directed by senior engineers, that build, run, and maintain software. DevHawk delivers it two ways, with deep experience across a range of industries.

ATLANTA, July 23, 2026 — Fraction, which since 2022 has given 175 companies access to senior US engineers without the cost of building a team, today announced it has evolved into DevHawk, an AI software factory: a suite of specialist AI agents, directed by senior engineers, that build, run, and evolve the software a business depends on. Companies can have DevHawk operate the factory for them, or run the agents with their own team.

“We built Fraction on a belief I’ve bet my whole career on: leverage beats headcount,” said Praveen Ghanta, Founder and CEO of DevHawk. “Small, senior teams with the right tools outbuild big ones, and they grow profitably instead of bloating the org chart. It’s how I built and sold my last company. Same belief now, with a much bigger engine.”

The agents cover the full engineering lifecycle, spanning up to nine disciplines from product and architecture to QA, DevOps, and security. They don’t just write code; they test it, ship it, and keep it running in production. A single senior engineer directing the suite can do work that once required six to ten people, shipping up to 10x faster and at 80-90% less than a traditional team.

DevHawk offers firms two paths, and positions itself as a partner in both. In the managed model, DevHawk’s senior engineers operate the software factory on the client’s behalf. In the self-serve model, a company adds the agents it needs to its own team and runs them, with DevHawk handling onboarding, integration, and ongoing support.

“It’s the best engineers in the game, 10x’d by a suite of specialized AI agents,” said Ghanta. “Run it with us, or we customize the agents and then you run them yourself.”

Since launching the software factory, DevHawk has seen a sharp uptick in demand from traditionally non-technical industries, including construction, logistics, and healthcare. Its deepest roots are in wealth management and fintech, where getting software wrong is not an option. As off-the-shelf tools stop fitting how these businesses run, more are choosing to own their own software rather than keep renting something that doesn’t fit.

“For the first time, every company can afford software built exactly for how they work,” said Ghanta, “instead of bending their business around off-the-shelf tools.”

About DevHawk
DevHawk (formerly Fraction) is an AI software factory. The company helps businesses build, run, and maintain the software they depend on using a suite of specialized AI agents, run by the company’s own team or operated by DevHawk. DevHawk was founded by Praveen Ghanta, a multiple-time founder who previously built and sold the wealth-technology platform HiddenLevers to Orion. Founded as Fraction in 2022 and headquartered in Atlanta, the company has served more than 175 companies across dozens of industries. Learn more at https://www.devhawk.ai.

Media Contact
Ali Murphy • [email protected] • 404.343.7747

SOURCE DevHawk

Hosted by JumpStart Inc. with premier support from Burton D. Morgan Foundation, the two-day event connects vision to venture through showcases, curated meetings and programming.

CLEVELAND, July 23, 2026 — JumpStart Inc. today announced that JumpStart VC Fest is returning to the Huntington Convention Center in downtown Cleveland on September 29 and 30, 2026. One of the Midwest’s largest innovation gatherings, VC Fest is JumpStart’s flagship event for entrepreneurs, investors, corporate leaders, policymakers and ecosystem leaders. With matchmaking for founders and funders from across the Midwest and beyond, the event, supported at the premier level by Burton D. Morgan Foundation, will bring together nearly one thousand participants for two days of programming, pitches and dealmaking.

For founders, VC Fest means a single trip that can replace months of scattered outreach — a chance to meet dozens of investors, potential customers and partners in one place through structured conversations, curated introductions and informal networking. For investors, it is a concentrated look at deal flow across the Midwest, without needing to travel from city to city to find it. And for Ohio, it is a visible marker of a growing tech economy, drawing outside capital and attention to a market that is still too often underappreciated.

“VC Fest is JumpStart’s mission in action at scale,” says JumpStart Inc. CEO Lorne Novick. “Connecting Vision to Venture is more than a theme. It is the charge behind our work: to open doors for entrepreneurs who are ready to build, compete and lead. By concentrating so much activity in one place, VC Fest gives high-potential founders and investors looking for their next high-growth investment  the kind of focused environment that can turn conversations into real movement.”

Now in its fourth year, JumpStart VC Fest continues to grow. In 2025, it attracted over 800 participants, including 298 founders and 110 investors from 38 states and 10 countries and facilitated more than 550 curated 1:1 meetings. This year’s agenda is focused on helping companies gain visibility and connect with capital and customer prospects that can help them move forward:

• Curated 1:1 meetings, the event’s centerpiece, facilitating targeted conversations between founders, investors and corporate partners, as well as investor-to-VC connections designed to surface opportunities, build relationships and accelerate dealmaking. (September 29 & 30)
• Startup showcases and pitches, featuring JumpStart Trailblazer Accelerator software and healthtech companies on Day 1, followed by 10 of the region’s most promising startups on Day 2. (September 29 & September 30, 12 – 1:30 p.m.)
• A Demo Zone, showcasing 20 promising early and growth-stage companies and giving them a platform to introduce themselves to potential investors, partners and mentors. (September 29, 9 – 11 a.m.)
• Keynote speakers, sharing insights from leading voices in venture capital and entrepreneurship on where the industry is headed. (September 29, 11 – 11:45 a.m. & September 30, 3:30 – 4:30 p.m.)
• Expert-led panels, featuring themed conversations with industry leaders on the trends, challenges and opportunities shaping entrepreneurship, technology, capital and economic growth. (September 29 & 30)
• A networking reception, giving attendees a relaxed setting for the organic connections between founders, funders and champions. (September 29, 5 – 6:30 p.m.)
• A Women in Tech Breakfast, bringing together women building, funding and championing the region’s tech economy. (September 30, 8:30 – 9:30 a.m.)
• An Investor Happy Hour, an exclusive gathering for investors to build relationships, exchange perspectives and explore co-investing opportunities in an offsite setting. (September 29, 6 – 7:30 p.m.)

Together, these elements are meant to do more than fill an agenda. They put companies in front of the people, capital and ideas that can shape their trajectory, while giving the Midwest innovation community a chance to show its full energy.

“Entrepreneurial potential is realized when bold ideas are met with the relationships, guidance and capital required to move them forward,” said Daniel Hampu, President and CEO of Burton D. Morgan Foundation. “VC Fest creates that kind of environment at a regional scale, bringing founders, investors, corporations and civic leaders together around a shared ambition for Northeast Ohio’s economy. We invite leaders from across the region and beyond to experience firsthand the caliber of the companies, talent and ideas emerging here, and to consider the role they can play in helping that momentum grow.”

Keynote speakers and panel session themes will be announced soon. Registration is now open, with tickets priced at $199 for founders and general attendees and $399 for investors and corporate attendees. Founder and investor tickets include curated matchmaking. To learn more and register, visit OhioVCFest.com.

About JumpStart Inc. JumpStart is a nonprofit organization whose mission is to drive economic vitality by connecting entrepreneurs to the opportunities and resources they need to succeed because when businesses thrive, communities benefit. Learn more at jumpstartinc.org.

About Burton D. Morgan Foundation
Burton D. Morgan Foundation is a private foundation based in Northeast Ohio dedicated to advancing the principles of free enterprise and entrepreneurship. Established in 1967 by visionary entrepreneur and philanthropist Burt Morgan, the foundation’s mission is to strengthen free enterprise by investing in people and entities that embody the entrepreneurial spirit. Through a combination of innovative programs, purposeful partnerships and strategic grantmaking, the foundation nurtures entrepreneurs of diverse ages and stages. Visit bdmorganfdn.org to learn more.

SOURCE JumpStart Inc.

Firm’s total capital commitments across funds and co-investment vehicles now exceed $600 million; Fund IV includes Savano’s first commitments from public pension plans

Fund IV has invested in 12 companies, including Steno, Vi Labs, and Lambda, and has realized investments in Reltio and Nozomi Networks

BALTIMORE, July 23, 2026 — Savano Capital Partners (“Savano”) today announced the final close of Savano Capital Partners IV, L.P. (“Fund IV”) with $252 million in capital commitments, exceeding its target. Fund IV is the largest fund in Savano’s history, approximately 60 percent larger than its predecessor, and brings total capital commitments across the firm’s funds and co-investment vehicles since inception to more than $600 million.

Fund IV received strong support from existing limited partners and added new institutional investors, including endowments, foundations, family offices and, for the first time in the firm’s history, two public pension plans. Several of the new investors are advised by leading institutional investment consultants.

Savano is a direct secondary investor focused on providing liquidity to individual shareholders and early investors in mature, high-growth software and technology companies. The firm works directly with companies and individual shareholders to structure targeted liquidity transactions. Savano often develops relationships with companies over time, supporting repeat liquidity programs as shareholder needs evolve.

“Every fund has focused on serving the same two constituencies: shareholders who need liquidity and companies that want a trusted partner while they build,” said Tom Smith, Managing Partner of Savano. “Fund IV is a validation of the strategy we have pursued for more than 15 years. We are grateful to our longtime limited partners and proud to welcome a new group of institutions. Their confidence lets us deliver thoughtful liquidity to the people who helped build these companies at a scale we could not reach before.”

Fund IV has invested in 12 companies across sectors including enterprise software, cybersecurity, data and AI infrastructure, financial technology and tech-enabled services. Current investments include Steno, Vi Labs, Docker and Lambda, among others. The fund has realized investments in Reltio, acquired by SAP in May 2026, and Nozomi Networks, acquired by Mitsubishi Electric in January 2026.

“The secondary market has moved from the edge of private markets to the center,” said Matt Good, Chief Operating Officer of Savano. “Great software companies now take a decade or longer to reach an exit, and the value created along the way needs a release valve. Founders, employees and early investors need practical ways to realize a portion of that value, and companies want those transactions handled thoughtfully and aligned with their long-term objectives. Savano was built for both sides of that equation.”

Since its founding, Savano has invested in more than 65 companies and completed more than 500 transactions.

Cooley LLP served as legal counsel in the formation of Fund IV.

About Savano Capital Partners

Founded in 2010 and headquartered in Baltimore, Maryland, Savano Capital Partners is a direct secondary investment firm focused on mature, high-growth software and technology companies. Savano provides liquidity to founders, employees and early investors through direct share purchases, working collaboratively with companies to support one-time or repeat shareholder liquidity programs.

To learn more, visit www.savanocapital.com. Savano Capital Partners refers to Savano Direct Capital Partners, LLC, a registered investment adviser.

Contact: [email protected]

SOURCE Savano Capital Partners

BAD HOMBURG, Germany, July 23, 2026 — The issuer is solely responsible for the content of this announcement.

Fresenius is further expanding its access to innovation networks through its own corporate venture capital fund. Fresenius Ventures invests in founders, technologies, and business models from early financing rounds through to the growth stage. The newly established unit combines venture capital with medical, regulatory, and operational expertise and provides access to clinical, scientific, and academic networks.

With an intended investment volume of more than €200 million over the next 5 years, Fresenius Ventures targets growth fields adjacent to Fresenius’ existing strategic platforms (Bio)Pharma, MedTech, and Care Provision. Potential investment areas of Fresenius Ventures include, for example, precision nutrition, microbiome research, new modalities, and digital care provision solutions. Investments will be made in line with Fresenius’ capital allocation approach.

Michael Sen, CEO of Fresenius, says: “Fresenius Ventures is a strategic instrument of #FutureFresenius. Through targeted investments in promising healthcare innovators, we gain early access to breakthrough technologies, new ideas, and entrepreneurial talent. This step enables us to strengthen our innovation capabilities within the healthcare ecosystem and tap into adjacent growth fields while consistently strengthening Fresenius. I am delighted that Dr. Thomas Michael Thestrup, a highly experienced healthcare and corporate venture capital expert, will lead Fresenius Ventures.”

Thomas Michael Thestrup joins Fresenius from Angelini Ventures, an international healthcare venture capital company and part of the Italian industrial group Angelini Industries.

“Fresenius Ventures backs the innovators shaping the next era of healthcare with the experience, pace, and conviction founders expect. We offer more than capital: deep operating and regulatory expertise across global markets, coupled with access to the clinical, scientific, and academic ecosystems where real progress happens today,” says Thomas Thestrup, Managing Director and Head of Fresenius Ventures.

Thomas Thestrup has more than 15 years of experience in research, health tech, and the pharma industry. Prior to Angelini Ventures, he worked for Lundbeck A/S as Director of Corporate Business Development and Strategy. Further positions prior to this include Global Business Development at UCB as well as Life Science Ventures at Sunstone Capital. Thomas Thestrup received his Ph.D. from the Max Planck Institute of Neurobiology in Munich.

For more information about Fresenius Ventures, please see: https://fresenius-ventures.com

A picture of Dr. Thomas Thestrup for editorial use can be found on our website https://www.fresenius.com/fresenius-ventures.

Press contact:

Edith Müller-Callsen
Group Communications
Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
T +49 160 9968 4046
[email protected]
[email protected] 

Fresenius (XFRA: FRE) (OTC: FSNUY) is a global, therapy-focused healthcare company dedicated to saving and improving human lives around the world. Through Fresenius Kabi and Fresenius Helios, the company delivers system-critical, innovative and affordable healthcare across the full continuum of care: Fresenius Kabi is a leading provider of lifesaving medicines, clinical nutrition, and medical technologies for critically and chronically ill patients, reaching around 450million peopleeach year. Fresenius Helios is Europe’s largest private hospital operator, treating around 27million patientsannually. 

With more than178,000employees and operating in more than 60 countries, Fresenius generated €22.6billion in revenue in 2025.

For more information, visit www.fresenius.com and follow Fresenius on LinkedIn. 

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, the availability of financing and unforeseen impacts of international conflicts. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius SE & Co. KGaA
Registered Office: Bad Homburg, Germany / Commercial Register: Amtsgericht Bad Homburg, HRB 11852
Chairman of the Supervisory Board: Wolfgang Kirsch

General Partner: Fresenius Management SE
Registered Office: Bad Homburg, Germany / Commercial Register: Amtsgericht Bad Homburg, HRB 11673
Management Board: Michael Sen (Chairman), Pierluigi Antonelli, Sara Hennicken, Dr. Michael Moser, Dr. Christian Pawlu
Chairman of the Supervisory Board: Wolfgang Kirsch

SOURCE Fresenius SE & Co. KGaA

OXFORD, England, July 23, 2026 — Moa Technology (“Moa”), an agricultural biotechnology company focused on discovering novel mode of action herbicides, announces a £22.2 million Series C financing round, co-led by Oxford Science Enterprises (“OSE”) and Supernova Invest (“Supernova”).

Joining Supernova as new investors in Moa are Agri Investment Fund (“AIF”); GrainInnovate, a fund investing on behalf of the Grain Research Development Corporation (“GRDC”) and managed by Artesian; Infinity Investment Partners; and Magdalen College Oxford. The round has also been supported by existing investors OSE, Lansdowne Partners, Parkwalk, and Oxford University Innovation.

This new investment reflects the proven strength of Moa’s IP and the progress it has made to become the innovation partner of choice for the crop protection industry. In the last 24 months, Moa has formed R&D collaborations with four leading companies – Nufarm, Gowan, Certis Belchim and Corteva Agriscience – to develop different novel solutions to help farmers protect their harvests from crop-killing weeds, and expects to continue to sign further commercial research partnerships. 

In a major breakthrough for the industry, Moa’s proprietary technology platforms have already discovered over 80 novel mode of action areas, which work in completely different ways to control weeds and break resistance. After successful validation in the lab and glasshouse, Moa’s most advanced novel mode of action programmes are performing strongly to control some of the world’s toughest weeds in successive seasons of international field trials. In 2025, the company discovered a new category of products – Moa Amplifiers™ – which are not herbicidal on their own but have the potential to reduce the amount or concentration of herbicides required, supporting productivity and environmental stewardship. 

The Series C funding will enable Moa to bring its three most advanced programmes significantly closer to commercialisation, to build its pipeline of early-stage novel mode of action herbicides and to further develop the Moa Amplifiers programme. The new equity investment will be supplemented by upfront and milestone payments from current and future industry partners working with Moa. 

Martin Fiennes of Oxford Science Enterprises, said: “When we helped spin Moa out from the University of Oxford’s Plant Sciences Department in 2017, we saw that its technology platform had a unique and important approach to address the market’s need for herbicides capable of breaking weed resistance. The success of the platform’s discoveries since in the lab and field trials has confirmed Moa is on track to provide the new solutions farmers need to sustain agricultural productivity, and we’re delighted to be supporting the company again in this fundraising round.”

Alexandre Biau of Supernova Invest, said: “Weed resistance continues to spread. It is causing increasing yield losses, further undermining the resilience of farming operations, while climate change is expected to make weed control even more challenging. In response, the Moa team is redefining the innovation playbook for weed control by advancing both novel modes of action and its Moa Amplifiers strategy, expanding the toolbox available to farmers. Building on the company’s strong momentum and proven ability to execute, Supernova Invest is proud to support Moa’s journey to market.” 

Dr Virginia Corless, CEO of Moa Technology said: “This marks a major milestone for Moa Technology – a validation of the outstanding progress we have made not just in the laboratory, but also in striking commercial deals with leading industry partners around the world. We are particularly pleased that, through AIF in Europe and GrainInnovate in Australia, the farming sector itself is closely connected to the next phase of Moa’s development, helping accelerate delivery of our solutions to the fields where they are so urgently needed.” 

About Moa Technology:

Spun out of Oxford University in 2017, Moa Technology aims to help farmers sustainably protect their harvests from crop-killing weeds and ensure food security for all. The company’s proprietary platforms have screened over 900,000 compounds and discovered more than 80 promising novel mode of action areas capable of breaking weed resistance to existing herbicides, with several advanced programmes now in their third year of international field trials. 

For more information, please visit www.moa-technology.com.

Photo: https://mma.prnewswire.com/media/3007284/Moa_CEO_Dr_Virginia_Corless.jpg

SOURCE Moa Technology

$BC has risen nearly 70% since April as BC Engine continues to expand the token‘s utility across the BC.GAME ecosystem

BELIZE CITY, Belize, July 22, 2026 — BC Token ($BC), the ecosystem token of BC.GAME, reached $0.02 on July 23, setting a new all-time high and extending its recent upward price movement.

According to CoinGecko, $BC reached the $0.02 milestone after moving steadily into a higher price range over the past several weeks. The token previously recorded a high of around $0.01561 on July 17 before continuing its upward movement.

Compared with its price of approximately $0.01181 on April 12, $BC has increased by nearly 70%. The latest milestone is also part of a series of new price records reached by the token since the launch of BC Engine in April.

Alongside the price growth, BC.GAME has continued to expand the practical use of $BC across its platform ecosystem.

Through BC Engine, users can allocate eligible $BC to the platform’s reward system and receive BCD rewards distributed on an hourly basis. Users can also view their allocated tokens, accumulated rewards and participation data directly through the BC Engine interface.

The system is designed to connect $BC participation with activity generated by products and partners across the wider BC.GAME ecosystem.

BC Originals, Croco Gaming and sports betting technology provider BETBY have already been integrated as Engine Nodes. Contributions from participating products and partners help support the BC Engine reward pool, creating a direct connection between platform activity, user participation and token utility.

“Reaching $0.02 is an important milestone for $BC, but price is only one part of the ecosystem’s continued development,” a BC.GAME spokesperson said. “Our focus remains on expanding the token‘s practical uses and connecting it more closely with products, rewards and user participation across the platform.”

The $BC ecosystem also includes separate buyback and token-burning mechanisms.

A portion of the tokens acquired through BC.GAME’s ongoing buyback activity may be redistributed to eligible active users through features such as Instant Bonus. The buyback programme operates separately from the token-burning mechanism.

Token burning is primarily connected to the BC Engine unlocking process. When users unlock $BC less than seven days after allocating it to BC Engine, 1% of the unlocked amount is permanently burned. Users who wait at least seven days can unlock the full amount without triggering a burn.

BC.GAME plans to introduce additional products and Engine Nodes while continuing to improve the visibility of reward distributions, token burns and other related on-chain activity.

The platform will also explore further uses for $BC across original games, sports betting and digital-asset reward experiences as the ecosystem continues to develop.

More information about BC Engine and the $BC ecosystem is available at bc.game/bc.

SOURCE BC.GAME

Transaction with Decathlon Capital Partners requires no dilution of current shareholders 

FARMINGTON, Utah, July 22, 2026 — Health Endeavors, LLC, a leading technology partner for Accountable Care Organizations (ACOs) and value-based care, today announced the launch of its AI-powered care management suite alongside a strategic growth-debt investment from Decathlon Capital Partners. Together, these milestones position the company to expand its reach and bring intelligent, scalable care solutions to a growing number of providers nationwide.

At the center of the new suite is Alex, a virtual care manager that engages tens of thousands of patients simultaneously. Alex educates and motivates patients, schedules appointments, collects data, and alerts care teams when human intervention is needed—all without practicing medicine. By keeping clinicians at the center of every decision, Alex closes care gaps and reduces provider burden. Alex is powered by OmniView, Health Endeavors’ platform that builds 360-degree digital patient profiles from claims, medical records, social determinants of health, and consumer data. The suite also includes MedPearl, a clinical decision support library developed at Providence Health, which gives clinicians evidence-based, point-of-care guidance and acts as a clinical guardrail for Alex’s patient interactions.

“Our unified intelligence platform delivers precise, hyper-personalized solutions that maximize efficiency, quality and impact,” said David Derrick, CEO of Health Endeavors. “Our partnership with Decathlon Capital Partners allows us to expand our robust solutions to a growing number of clients.”

The investment reflects Decathlon Capital Partners’ confidence in the future of value-based care. “Accountable Care Organizations and value-based care are focused on successful patient outcomes, and Health Endeavors provides the actionable insights that allow providers to deliver effective care,” said Matt Hoffman, Managing Director of Decathlon Capital Partners. “Decathlon Capital Partners is proud to work with Health Endeavors to advance a proactive, prevention-focused approach to healthcare.”

About Health Endeavors
Headquartered in Farmington, Utah, Health Endeavors, LLC has more than 16 years of experience helping Accountable Care Organizations and value-based arrangements thrive. The company serves over 2 million patients, partnering with clinical equity leaders Novant Health and Providence to deliver AI-driven patient engagement. As an ONC Certified (eCQM) Vendor and Medicare Qualified Registry, Health Endeavors turns data into action, staying true to its mission of returning resources, power, and joy to the point of care. For more information, visit https://healthendeavors.com.

About Decathlon Capital Partners 
Decathlon Capital Partners provides growth capital for companies seeking alternatives to traditional equity investment. Through the use of highly customized growth-debt financing solutions, Decathlon provides long-term growth capital without the dilution, loss of control and operational overhead that often comes with equity-based funding. With offices in Palo Alto and Park City, Decathlon is active across a wide range of sectors. Learn more at www.decathloncapital.com.

SOURCE Health Endeavors

DALLAS, July 22, 2026 — Cosmetic Physician Partners (CPP), the majority practitioner-owned medical aesthetics network spanning 75+ clinics across the United States, today announced it has paid out nearly $35 million directly to its partners, the doctors, nurses and employees who own the business, in the company’s second such payout to date.

The distribution brings the total CPP has returned to its partners to more than $60 million across two rounds, and the company intends to continue returning capital.

CPP is majority-owned by the practitioners and staff who run its clinics, and the company credits its ability to pay out capital to the strength of its people. Industry-leading staff retention, consistently high patient satisfaction, and a culture built to support clinicians have produced the quality of care and operating performance that make recurring payouts possible. CPP is believed to be the first and only aesthetics network to have returned capital directly to its practitioner-shareholders, having now completed two distributions.

“This is what happens when you build a company around your people,” said Dan Schacter, CEO and co-founder of CPP. “Our partners stay because they own the business and they love the work. The quality of care our clinicians deliver, and the trust they build with patients are exactly what allow us to return capital to our people with more to come.”

The result is one of the most stable operating platforms in medical aesthetics: clinicians who stay, patients who return, and a culture that gives practitioners genuine autonomy and ownership.

CPP is also the only national aesthetics network of its scale with NO private equity (PE) investment in the business. The company carries low debt and has no preferred shares, every owner earns the same return, which puts the doctors, nurses and employees who run the clinics on equal economic footing with every other shareholder.

About Cosmetic Physician Partners

Cosmetic Physician Partners (CPP) is a practitioner-owned medical aesthetics network of 75+ clinics across the United States. CPP is majority-owned by the doctors, nurses and employees who operate its clinics and is built on strong staff retention, high-quality patient care, and a culture that supports its people. That foundation has enabled CPP to pay out capital to its partner-owners, a distinction shared by few in the industry.

For information:

Sean Walsh
VP of Partnerships
[email protected]

SOURCE Cosmetic Physician Partners